Cardio-Metabolic Disorders
Cardio-metabolic disorders, which include conditions such as obesity, diabetes, metabolic syndrome, and dyslipidemia, have become some of the most significant risk factors for cardiovascular disease. Cardio-Metabolic Disorders mainly focus on the pathophysiology of these interconnected conditions and their contribution to cardiovascular risk. Innovative treatments for these disorders, including GLP-1 receptor agonists, SGLT2 inhibitors, and newer lipid-lowering therapies like PCSK9 inhibitors, will be highlighted. The impact of bariatric surgery in reversing some of the underlying metabolic disturbances and improving cardiovascular outcomes will also be discussed. The role of early screening for metabolic risk factors, including regular blood glucose and lipid level assessments, will also be emphasized. As the global prevalence of obesity and metabolic disorders continues to rise, an integrated approach to managing these conditions is crucial in reducing the burden of cardiovascular disease worldwide. The role of early screening for metabolic risk factors, including regular blood glucose and lipid level assessments, will be emphasized. As the global prevalence of obesity and metabolic disorders continues to rise, an integrated approach to managing these conditions is crucial in reducing the burden of cardiovascular disease worldwide.